{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/TTRX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-16T01:23:09.684Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":11189,"canonical_name":"Turn Therapeutics Inc.","cik":"0002023016","uei":null,"lei":null,"duns":null,"ticker":"TTRX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":26},"count":26,"timeline":[{"ts":"2026-10-07","kind":"sec.filing","form_type":"8-K","title":"8-K — Turn Therapeutics Inc. — 2026-10-07","url_slug":"/sec/cik-0002023016/8-k/0001213900-26-107329","accession_number":"0001213900-26-107329","importance":35},{"ts":"2026-09-10","kind":"sec.filing","form_type":"8-K","title":"8-K — Turn Therapeutics Inc. — 2026-09-10","url_slug":"/sec/cik-0002023016/8-k/0001213900-26-098584","accession_number":"0001213900-26-098584","importance":35},{"ts":"2026-09-09","kind":"sec.filing","form_type":"8-K","title":"8-K — Turn Therapeutics Inc. — 2026-09-09","url_slug":"/sec/cik-0002023016/8-k/0001213900-26-098224","accession_number":"0001213900-26-098224","importance":35},{"ts":"2026-08-26","kind":"sec.filing","form_type":"D","title":"D — Turn Therapeutics Inc. — 2026-08-26","url_slug":"/sec/cik-0002023016/d/0002023016-26-000001","accession_number":"0002023016-26-000001","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"8-K","title":"8-K — Turn Therapeutics Inc. — 2026-08-18","url_slug":"/sec/cik-0002023016/8-k/0001213900-26-091002","accession_number":"0001213900-26-091002","importance":35},{"ts":"2026-08-17","kind":"sec.filing","form_type":"8-K","title":"8-K — Turn Therapeutics Inc. — 2026-08-17","url_slug":"/sec/cik-0002023016/8-k/0001213900-26-090766","accession_number":"0001213900-26-090766","importance":35},{"ts":"2026-08-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Turn Therapeutics Inc. — 2026-08-12","url_slug":"/sec/cik-0002023016/10-q/0001213900-26-088427","accession_number":"0001213900-26-088427","importance":45},{"ts":"2026-08-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Turn Therapeutics Inc. — 2026-08-12","url_slug":"/sec/cik-0002023016/8-k/0001213900-26-088411","accession_number":"0001213900-26-088411","importance":35},{"ts":"2026-07-28","kind":"sec.filing","form_type":"8-K","title":"8-K — Turn Therapeutics Inc. — 2026-07-28","url_slug":"/sec/cik-0002023016/8-k/0001213900-26-081996","accession_number":"0001213900-26-081996","importance":35},{"ts":"2026-07-07","kind":"sec.filing","form_type":"8-K","title":"8-K — Turn Therapeutics Inc. — 2026-07-07","url_slug":"/sec/cik-0002023016/8-k/0001213900-26-075757","accession_number":"0001213900-26-075757","importance":35},{"ts":"2026-06-08","kind":"sec.filing","form_type":"4","title":"4 — Turn Therapeutics Inc. — 2026-06-08","url_slug":"/sec/cik-0002023016/4/0001213900-26-066391","accession_number":"0001213900-26-066391","importance":30},{"ts":"2026-06-08","kind":"sec.filing","form_type":"4","title":"4 — Turn Therapeutics Inc. — 2026-06-08","url_slug":"/sec/cik-0002023016/4/0001213900-26-066395","accession_number":"0001213900-26-066395","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"8-K","title":"8-K — Turn Therapeutics Inc. — 2026-06-03","url_slug":"/sec/cik-0002023016/8-k/0001213900-26-064405","accession_number":"0001213900-26-064405","importance":35},{"ts":"2026-06-01","kind":"sec.filing","form_type":"8-K","title":"8-K — Turn Therapeutics Inc. — 2026-06-01","url_slug":"/sec/cik-0002023016/8-k/0001213900-26-063177","accession_number":"0001213900-26-063177","importance":35},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — Turn Therapeutics Inc. — 2026-06-01","url_slug":"/sec/cik-0002023016/4/0001213900-26-063629","accession_number":"0001213900-26-063629","importance":30},{"ts":"2026-05-28","kind":"sec.insider.g","reporter":"Burnam Bradley Evan","title":"Chief Executive Officer","shares":300000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-28","kind":"sec.insider.g","reporter":"BEB Holdings, LLC","title":"","shares":300000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-28","kind":"sec.insider.g","reporter":"Burnam Bradley Evan","title":"Chief Executive Officer","shares":300000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-28","kind":"sec.insider.g","reporter":"BEB Holdings, LLC","title":"","shares":300000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-28","kind":"sec.insider.g","reporter":"Burnam Bradley Evan","title":"Chief Executive Officer","shares":300000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-28","kind":"sec.insider.g","reporter":"BEB Holdings, LLC","title":"","shares":300000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-28","kind":"sec.insider.g","reporter":"Burnam Bradley Evan","title":"Chief Executive Officer","shares":300000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-28","kind":"sec.insider.g","reporter":"BEB Holdings, LLC","title":"","shares":300000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-19","kind":"sec.filing","form_type":"8-K","title":"8-K — Turn Therapeutics Inc. — 2026-05-19","url_slug":"/sec/cik-0002023016/8-k/0001213900-26-058730","accession_number":"0001213900-26-058730","importance":35},{"ts":"2026-05-18","kind":"sec.filing","form_type":"8-K","title":"8-K — Turn Therapeutics Inc. — 2026-05-18","url_slug":"/sec/cik-0002023016/8-k/0001213900-26-058140","accession_number":"0001213900-26-058140","importance":35},{"ts":"2026-05-13","kind":"sec.filing","form_type":"C-TR","title":"C-TR — Turn Therapeutics Inc. — 2026-05-13","url_slug":"/sec/cik-0002023016/c-tr/0001213900-26-055361","accession_number":"0001213900-26-055361","importance":30}]}